Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.5975
-0.0045 (-0.75%)
Sep 4, 2026, 1:54 PM EDT - Market open
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $16.4 million as of September 4, 2026. Its market cap has decreased by -21.14% in one year.
Market Cap
16.40M
Enterprise Value
6.57M
1-Year Change
-21.14%
Ranking
Category
Stock Price
$0.60
ChartMarket Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $16.40M, a decrease of -46.57%. That is a compound annual growth rate of -6.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 16.40M | 1.88% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 17.58M |
| BioCardia | 16.80M |
| Psyence Biomedical | 16.67M |
| Adial Pharmaceuticals | 16.60M |
| Pluri | 15.32M |
| BioVie | 15.31M |
| Vyome Holdings | 15.30M |
| NeuroSense Therapeutics | 15.19M |